Mabtas T 500 mg Injection
$505,92
$200,33
Mabtas T 500 mg Injection is a potent monoclonal antibody that plays a crucial role in the management of various immune-related conditions, particularly targeting certain malignancies such as non-Hodgkin's lymphoma and chronic lymphocytic leukemia. By specifically binding to cancerous cells, Mabtas T helps to modulate the immune response, effectively aiding the body in its fight against these diseases. This targeted therapy is often recommended for patients who have not responded adequately to conventional treatments. However, it is essential to be aware of potential side effects, which may include infusion reactions and increased susceptibility to infections, necessitating close monitoring during treatment. Patients should consult their healthcare provider for a comprehensive assessment to ensure Mabtas T is an appropriate option for their condition. With its unique mechanism of action, Mabtas T offers hope for improved outcomes in oncology patients, enhancing both survival rates and quality of life. As always, adherence to medical guidance is crucial for maximizing the benefits of this innovative therapy while minimizing risks.
數量
Active Pharmaceutical Ingredient
Uses
• Mabtas t 500 mg injection is primarily used in the treatment of Non-Hodgkin lymphoma (NHL). This medication targets specific cells involved in the cancer process, helping to slow the progression of the disease. Patients receiving Mabtas t 500 mg injection may experience improved outcomes in their overall treatment plan. It is often administered as part of a broader chemotherapy regimen.
• In addition to NHL, Mabtas t 500 mg injection is also indicated for managing rheumatoid arthritis. This condition involves chronic inflammation of the joints, leading to pain and stiffness. By utilizing Mabtas t 500 mg injection, healthcare providers aim to reduce inflammation and enhance the quality of life for patients. The injection helps to modulate the immune response, providing significant relief from symptoms.
• Mabtas t 500 mg injection is effective in treating chronic lymphocytic leukaemia (CLL), a type of blood cancer. The medication works by targeting the abnormal cells responsible for the disease, thereby aiding in their destruction. Patients with CLL receiving Mabtas t 500 mg injection may notice a decrease in disease symptoms and an improved overall health status. This treatment is often part of a comprehensive therapeutic approach.
• Another important use of Mabtas t 500 mg injection is in the management of granulomatosis with polyangiitis and microscopic polyangiitis. These conditions involve inflammation of blood vessels, which can lead to various organ complications. By administering Mabtas t 500 mg injection, doctors aim to suppress the abnormal immune response and minimize damage to affected tissues. This targeted approach can help stabilize the condition and improve patient outcomes.
Benefits
Non-Hodgkin lymphoma (NHL): Non-Hodgkin's lymphoma is a form of cancer that affects the white blood cells in the body. These cells are responsible for preventing infections. Mabtas T 500 mg Injection has been demonstrated to reduce the immune response and relieve pain and inflammation. It also can kill cancer cells and prevent their further growth. To prevent the spread of infection, it is advisable to avoid crowds and to wash your hands frequently. It is recommended that patients consume an adequate quantity of fluids unless otherwise advised by their physician. Rheumatoid arthritis: Mabtas T 500 mg is an immunosuppressant that is used to treat rheumatoid arthritis. It is administered in a dose and frequency that is tailored to the patient's condition. This is determined by the physician. It is crucial to adhere to the physician's instructions and to promptly report any adverse effects, including fever, chills, or other symptoms, to the physician. Blood cancer (Chronic lymphocytic leukaemia): Leukaemia, also known as blood cancer, is a malignant neoplasm of the haematopoietic tissues that impairs the body's ability to combat infection. Mabtas T 500 Injection is a chemotherapeutic agent that kills or inhibits the proliferation of malignant cells and is effective in the treatment of leukaemia. However, it is important to discuss the potential side effects and benefits of this medication with a qualified healthcare professional. It is also essential to inform your doctor of any adverse effects that may arise during treatment. Granulomatosis with polyangiitis: Granulomatosis with polyangiitis (GPA) is a condition that causes inflammation of the blood vessels of the ears, nose, throat, lungs, and kidneys. In this condition, the blood flow to these areas may be reduced, which can lead to their damage. Mabtas T 500 mg Injection is an effective treatment that helps reduce inflammation, pain, and swelling and prevents further damage. This improves the quality of life of those affected by GPA. Microscopic polyangiitis: Microscopic polyangiitis is an autoimmune disease that affects the small blood vessels and may be caused by an imbalance in the immune system. Mabtas T 500 Injection reduces the immune response and improves inflammation. This helps to heal the condition and to alleviate discomfort.
Side Effects
Mabtas T 500 mg Injection can cause various adverse effects that can differ from one person to another. Some of the adverse effects of the drug are listed below.
Most Common Side Effects
• Low Immunity
• Nausea
• Tinnitus
• Muscle Pain and Stiffness
• Face Swelling
• Low Blood Count of White Blood Cells and Red Blood Cells
• Increase in Glucose Levels in Blood
• Headache
Common Side Effects
• Skin Reactions
• Heart Problems
• Infections
• Allergies
How To Use
The administration of Mabtas T 500 mg Injection is typically conducted by a medical professional, such as a doctor or nurse, in a medical facility, such as a hospital or clinic. It is not advisable to administer the product independently, and it is important to adhere to the instructions provided by a qualified healthcare professional.
Safety Advice
• Alcohol: Caution should be exercised when drinking alcohol with Mabtas T 500 mg. Please consult your doctor.
• Kidney: Mabtas T 500 Injection is likely to be safe in patients with kidney disease. The limited data available suggest that dose adjustment of Vortuxi Solution for Infusion may not be necessary for these patients. Please consult your doctor.
• Breastfeeding: Mabtas T 500 mg Injection is likely to be safe to use while breast-feeding, and limited human statistics support that the drug now no longer poses a good risk to the baby.
• Liver: Mabtas T 500 mg Injection is not recommended in patients with active liver disease or those who have had viral hepatitis. Please consult your doctor.
• Pregnancy: Mabtas T 500 mg Injection may not be safe for use during pregnancy. Although there is limited human research, animal research has shown dangerous effects on the growing baby. Your doctor will weigh up the benefits and potential risks before prescribing it to you. Please consult your doctor.
• Driving: It is not known whether Mabtas T 500 mg affects your ability to drive. Do not drive if you experience symptoms that affect your ability to concentrate and react.